The "la Caixa" Foundation will allocate €150,000 to develop this project led by Eugenia Martínez Hernández, from the Pathogenesis of autoimmune neuronal disorders group, in consortium with Antonel...
Read more
The Lleida-based research group Biochemistry of Oxidative Stress is leading a study to determine the onset of the effects on the cells of people suffering from this disease
Read more
A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of pr...
Read more
ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1
Read more
El Laboratorio de Neurociencia Celular y Plasticidad de la Universidad Pablo de Olavide demuestra que los astrocitos, a través de la molécula D-serina, son esenciales en el proceso de reorganizació...
Read more
Desde su constitución en 2018 como una spin-off biotecnológica, Biointaxis ha centrado sus esfuerzos en el desarrollo de FRATAXAV®, un fármaco de terapia génica que permite acceder al sistema ner...
Read more
The study analysed head impacts among professional footballers in World Cup matches over a period of 50 years, and observed a significant number of these diseases. It is predicted that this will lead ...
Read more
Un estudio liderado desde la Universidad Autónoma de Madrid (UAM) revela que el reposicionamiento del fármaco dimetil fumarato reduce la degeneración neuronal en un modelo de ratón con demencia fr...
Read more
El estudio genómico de más de 20000 pacientes con epilepsia identifica factores genéticos implicados en la enfermedad y plantea nuevas dianas para el desarrollo de tratamientos.
Read more
Alfons Carnicero: “ABLE Human Motion was created almost 6 years ago with the vision of democratising robotic exoskeletons. After launching the product for clinical use we are now working on a new ro...
Read more
A research study led by the University of Barcelona describes how brain neurons in mice can be rejuvenated through a controlled cellular reprogramming cycle that helps to recover some altered neurolog...
Read more
Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the nine months...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
